http://www.evrs.eu/medias/2006/congress/Short-term-Outcomes-in-Over-500-Intravitreal-Bevacizumab-Treatments-for-Retinal-or-Choroidal-Vascular-Disease-at-the-New-York-Eye-Ear-Infirmary.swf Thomas O. Muldoon, MD (New York, NY), Richard B. Rosen, MD (New York, NY), Sean C. Lalin, MD (New York, NY), Jeanette Dominguez, MD (New York, NY), Ronald C. Gentile, MD(New York, NY) PURPOSE: Assess the short-term outcomes in patients who received...
Read MoreShort-term Outcomes in Over 500 Intravitreal Bevacizumab Treatments for Retinal or Choroidal Vascular Disease at the New York Eye & Ear Infirmary
Posted by Thomas O. Muldoon, Richard B. Rosen, Sean C. Lalin, Jeanette Dominguez and Ronald C. Gentile on Oct 1, 2006 in Bevacizumab Avastin, Macular Edema, OCTs, Vascular diseases
Dualing OCT Modalities: Contrasting Retinal Features Revealed by a Dual Mode High Speed Ultrahigh Resolution Spectral and Temporal OCT/SLO Imager
Posted by Richard B. Rosen, Patricia Garcia, Mark Hathaway, Thomas O. Muldoon, Ronald C. Gentile, Sean C. Lalin, Eric W Fitz, John Rogers, Justin Pedro and Adrian Podoleanu on Oct 1, 2006 in OCTs, Scanning laser ophthalmoscopy
Richard B. Rosen, MD (New York, NY), Patricia Garcia, MD (New York, NY),* Mark Hathaway, PhD (Canterbury, Kent, UK),* Thomas Muldoon, MD (New York, NY), Ronald Gentile, MD (New York, NY), Sean Lalin, MD (New York, NY), Eric Fitz, MD (New York, NY), John Rogers, PhD (Canterbury, Kent, UK),* Justin Pedro, PhD (Toronto, Canada),* Adrian Podoleanu, PhD (Canterbury, UK)* PURPOSE: To describe new aspects of common retinal pathologies revealed by...
Read More